Novo integrated sciences enters into purchase agreement to acquire clinical consultants international llc

Bellevue, wash.--(business wire)---- $nvos #benzinga--novo integrated sciences, inc. (nasdaq: nvos) (the “company” or “novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation, has signed a membership interest purchase agreement (“mipa”) to acquire clinical consultants international llc (“cci”) in an all-stock transaction (the “transaction”). the transaction is expected to close no later than april 15, 2022. esta
NVOS Ratings Summary
NVOS Quant Ranking